alexa Increasing Access With Biosimilars
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Biowaivers, Biologics & Biosimilars
October 27-29, 2014 Hyderabad International Convention Centre, Hyderabad, India

Steven Lehrer
Keynote: J Bioanal Biomed
DOI: 10.4172/1948-593X.S1.012
Abstract
Access is a function of accessibility (or reach), availability, acceptability (quality) and affordability. Developed nations have most dimensions addressed, leaving scope for improvement on affordability (yes, even where insurance exists) while developing nations face challenges along all dimensions Drugs enter the Access Ecosystem only on availability and affordability ? ie ? Are the drugs required to treat patients available where and when patients need them? ? Are the drugs affordable to the entire population? When we look at India today, even if biosimilars were to be easily available and somewhat affordable, we need to ask ourselves: ? How do we make sure there are enough physicians and paramedical staff to diagnose and treat patients with biologicals? ? How do we make sure that patients are getting the right treatments at the right time in the correct doses? ? How do we make sure that biologicals reach patients/hospitals where used/administered? ? How do we ensure that they are stored correctly through out their journey from the distributor to the end patient? ? Are we truly bring them within the reach of many and not just beyond the privileged few? ? What are the measures we have in place to make sure that the drugs are safe for patients to use? Only if we are addressing these questions will the true value of biosimilars be fully realised
Biography
Steven Lehrer is a proven business leader having 25 years of experience in commercializing multiple life science technologies. During this period, he started and built businesses in both small and large companies. Steve has extensive international experience in leading businesses, creating alliances / partnerships in several world areas. After having completed his bachelors in Science from University of Maryland, Steve went on to earn an MBA from the renowned Harvard School of Business. Steve has worked in Proctor and Gamble, McKinsey and Monsanto during the initial years of his career before embarking onto a career helping set up and build business in biotechnology for numerous organisations across the globe.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords